Jane Huang
President at PRELUDE THERAPEUTICS INCORPORATED
Net worth: 243 246 $ as of 2024-03-30
Profile
Dr. Jane E. Huang, MD, is a Chief Medical Officer-Hematology at BeiGene Ltd. Dr. Huang was previously employed as a Vice President & Head-Clinical Development by Acerta Pharma BV and a Group Medical Director by Genentech, Inc. She received her undergraduate degree from Stanford University and a doctorate degree from Washington University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-03 | 51,287 ( 0.09% ) | 243 100 $ | 2024-03-30 | |
BEIGENE LTD
0.00% | 2023-04-16 | 12 ( 0.00% ) | 146 $ | 2024-03-30 |
| 2023-06-06 | 0 ( -.--% ) | - $ | 2024-03-30 |
Jane Huang active positions
| Companies | Position | Start |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Director/Board Member | 2021-06-08 |
| PRELUDE THERAPEUTICS INCORPORATED | President | 2022-04-03 |
858 Therapeutics, Inc.
 858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | Director/Board Member | 2022-04-04 |
Former positions of Jane Huang
| Companies | Position | End |
|---|---|---|
| BEIGENE, LTD. | Chief Tech/Sci/R&D Officer | 2022-04-02 |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Corporate Officer/Principal | 2016-08-31 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2015-02-28 |
Training of Jane Huang
| Stanford University | Undergraduate Degree |
| Washington University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BEIGENE, LTD. | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| PROTARA THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Health Technology |
858 Therapeutics, Inc.
858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Jane Huang
